Daguplo, Julio S.
HRN: 27-03-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2025
CEFTRIAXONE 1G (VIAL)
04/24/2025
04/30/2025
IVTT
2g
OD
TBI; Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes